Trails Edge Capital Partners, LP - Jul 14, 2025 SCHEDULE 13G Report for Milestone Pharmaceuticals Inc. Common Shares (MIST)

Filing Manager
Trails Edge Capital Partners, LP
Reporting Manager
Trails Edge Capital Partners, LP
Security
Milestone Pharmaceuticals Inc. Common Shares
Symbol
MIST
Shares outstanding
89.4M shares
Disclosed Ownership
8.85M shares
Ownership
9.9%
Form type
SCHEDULE 13G
Date filed
7/21/2025, 04:30 PM
Date of event
Jul 14, 2025
Next filing
Nov 14, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Trails Edge Capital Partners, LP 9.9% 8.85M 8.85M 0 By: Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP 9.9% 8.85M 8.85M 0 By: Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai 9.9% 8.85M 8.85M 0 /s/ Ortav Yehudai Ortav Yehudai / Individual